“The delta vari­ant is like a com­mon cold, but …”: Matteo Bassetti, noto infet­tivol­o­go tele­vi­si­vo: “La vari­ante Delta è come un sem­plice raf­fred­dore ma sono con­tento se si usa per fare ter­ror­is­mo per vac­cinare la gente!” Un medico che sposa la strate­gia del ter­rore deve essere denun­ci­a­to e radi­a­to dall’Albo dei medici. pic.twitter.com/YnPEvv0Mhe — RadioSavana (@RadioSavana) August 3, 2021 Why would one want to get vac­ci­nat­ed against the com­mon cold (which coro­n­avirus­es have caused prob­a­bly since humans exist)? A pro­fes­sor of med­i­cine who states such illog­i­cal­i­ty vio­lates his hip­po­crat­ic oath, and not only. He is respon­si­ble for phys­i­cal harm that vac­ci­na­tion causes 
The “trad­ing action” in finan­cial mar­kets con­tin­ues to be most­ly con­gru­ent with the “max­i­mal uncer­tain­ty” that we estab­lished as the state gov­ern­ing the post-elec­tion sit­u­a­tion. By now, how­ev­er, we believe we are able to make a call for the out­come of the 2020 US pres­i­den­tial elec­tion based on legal considerations. 
While we are cur­rent­ly work­ing on oth­er urgent mat­ters and have hard­ly any time to fol­low up on the the throat dis­in­fec­tion com­plex, let us – very briefly – make the fol­low­ing addi­tion­al com­ments with regard to the study under­way in Kentucky. If noth­ing else, they may serve as a men­tal check to the study inves­ti­ga­tors (who we will make aware of them, of course). 
A group of researchers from the UK (Cardiff and Cambridge), the US (Denver, Colorado), Spain (Barcelona), and Canada (Ottawa) has now picked up the idea we have put for­ward almost exact­ly two months ago for pre­ven­tive throat dis­in­fec­tion with viru­ci­dal agents that are known to be effec­tive against coro­n­avirus­es and safe to use in the throat. The WHO should now even more seri­ous­ly con­sid­er includ­ing it in its recommendations. 
COVID-19, many believe, has thrown the world into unprece­dent­ed dis­as­ter, and to those believ­ing so, the future looks bleak at best. But what if the oppo­site will prove to be true? Speculation is a noble occu­pa­tion, futures stud­ies an aca­d­e­m­ic dis­ci­pline, so we haz­ard a brief pre­view of the enor­mous eco­nom­ic and soci­etal gains for which the COVID-19 cri­sis may have just sown the seeds. 
While in recent weeks we have been focused on estab­lish­ing and com­pre­hend­ing as deeply as pos­si­ble the immuno­log­i­cal “big pic­ture” in viral epi­demics from so far only part­ly inter­con­nect­ed evi­dence in the spe­cial­ist lit­er­a­ture, in order to derive action­able rec­om­men­da­tions, we briefly sum­ma­rize what has emerged in terms of feed­back as well as addi­tion­al insight with regard to our first arti­cle since it appeared.